Scientists used an optimized, more precise version of CRISPR-Cas9 gene-editing to prevent deafness in Beethoven mice with no detectable off-target effects, treating the same genetic mutation that causes progressive hearing loss in humans, culminating in profound deafness by their mid-20s.
No comments:
Post a Comment